icon-folder.gif   Conference Reports for NATAP  
 
  EASL 2024
June 5-8, Milan, Italy 		Back grey_arrow_rt.gif
 
 
 
Assessment of resmetirom efficacy (80 mg vs. 100 mg) stratified by baseline body mass index and weight in patients from the MAESTRO-NASH trial
 
 
  EASL 2024 June 5-8 Milan Italy
 
Mazen Noureddin
Houston, TX, United States

0611241

0611242

0611243

0611244

0611245

0611246

0611247

0611248